| Iron-overload-related disease in HFE hereditary hemochromatosis A KJ N Engl J Med. 358 (3), 221-30, 2008 | 867* | 2008 |
| Iatrogenic Creutzfeldt–Jakob disease at the millennium P Brown, M Preece, JP Brandel, T Sato, L McShane, I Zerr, A Fletcher, ... Neurology 55 (8), 1075-1081, 2000 | 705 | 2000 |
| Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease I Zerr, M Pocchiari, S Collins, JP Brandel, J de Pedro Cuesta, RSG Knight, ... Neurology 55 (6), 811-815, 2000 | 601 | 2000 |
| Web-based recruiting for health research using a social networking site: an exploratory study Y Fenner, SM Garland, EE Moore, Y Jayasinghe, A Fletcher, SN Tabrizi, ... Journal of medical Internet research 14 (1), e20, 2012 | 506 | 2012 |
| Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study S Collins, MG Law, A Fletcher, A Boyd, J Kaldor, CL Masters The lancet 353 (9154), 693-697, 1999 | 281 | 1999 |
| Quinacrine does not prolong survival in a murine Creutzfeldt‐Jakob disease model SJ Collins, V Lewis, M Brazier, AF Hill, A Fletcher, CL Masters Annals of Neurology: Official Journal of the American Neurological …, 2002 | 193 | 2002 |
| HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis‐related morbidity LC Gurrin, NA Bertalli, GW Dalton, NJ Osborne, CC Constantine, ... Hepatology 50 (1), 94-101, 2009 | 151 | 2009 |
| Cohort profile: the Melbourne collaborative cohort study (health 2020) RL Milne, AS Fletcher, RJ MacInnis, AM Hodge, AH Hopkins, JK Bassett, ... International journal of epidemiology 46 (6), 1757-1757i, 2017 | 122 | 2017 |
| Creutzfeldt-Jakob disease: diagnostic utility of 14–3–3 protein immunodetection in cerebrospinal fluid S Collins, A Boyd, A Fletcher, M Gonzales, CA McLean, K Byron, ... Journal of Clinical Neuroscience 7 (3), 203-208, 2000 | 96 | 2000 |
| HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 μg/L are at low risk of hemochromatosis KJ Allen, NA Bertalli, NJ Osborne, CC Constantine, MB Delatycki, ... Hepatology 52 (3), 925-933, 2010 | 68 | 2010 |
| Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease S Collins, A Boyd, A Fletcher, MF Gonzales, CA McLean, CL Masters Journal of clinical neuroscience 7 (3), 195-202, 2000 | 58 | 2000 |
| Creutzfeldt–Jakob disease in Australia 1970–1999 S Collins, A Boyd, JS Lee, V Lewis, A Fletcher, CA McLean, M Law, ... Neurology 59 (9), 1365-1371, 2002 | 55 | 2002 |
| Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease S Collins, A Boyd, A Fletcher, K Byron, C Harper, CA McLean, CL Masters Archives of neurology 57 (7), 1058-1063, 2000 | 53 | 2000 |
| Incidence of Invasive Breast Cancer and Ductal Carcinoma In situ in a Screening Program by Age: Should Older Women Continue Screening? B Erbas, A Amos, A Fletcher, AM Kavanagh, DM Gertig Cancer Epidemiology Biomarkers & Prevention 13 (10), 1569-1573, 2004 | 44 | 2004 |
| Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site B Gunasekaran, Y Jayasinghe, Y Fenner, EE Moore, JD Wark, A Fletcher, ... Sexually transmitted infections 89 (4), 327-329, 2013 | 37 | 2013 |
| Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12‐year study SG Zaloumis, KJ Allen, NA Bertalli, L Turkovic, MB Delatycki, AJ Nicoll, ... Journal of gastroenterology and hepatology 30 (4), 719-725, 2015 | 36 | 2015 |
| Attitudes to Chlamydia screening elicited using the social networking site Facebook for subject recruitment N Ahmed, Y Jayasinghe, JD Wark, Y Fenner, EE Moore, SN Tabrizi, ... Sexual health 10 (3), 224-228, 2013 | 31 | 2013 |
| Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis AS Fletcher, B Erbas, AM Kavanagh, S Hart, A Rodger, DM Gertig The Breast 14 (3), 192-200, 2005 | 30 | 2005 |
| Topical corticosteroid allergy in an urban Australian centre NR Keegel T, Saunders H, Milne R, Sajjachareonpong P, Fletcher A Contact Dermatitis 50, 6-14, 2004 | 30 | 2004 |
| Duration of hormone replacement therapy, breast tumour size and grade in a screening programme DM Gertig, B Erbas, A Fletcher, A Amos, AM Kavanagh Breast cancer research and treatment 80, 267-273, 2003 | 29 | 2003 |
